Advertisement

Recreational Drug Consumption

An Economic Perspective

  • Pratima Ramful Srivastava

Part of the Developments in Health Economics and Public Policy book series (HEPP, volume 11)

Table of contents

  1. Front Matter
    Pages i-vii
  2. Pratima Ramful Srivastava
    Pages 1-7
  3. Pratima Ramful Srivastava
    Pages 9-24
  4. Pratima Ramful Srivastava
    Pages 25-44
  5. Pratima Ramful Srivastava
    Pages 45-72
  6. Pratima Ramful Srivastava
    Pages 73-97
  7. Pratima Ramful Srivastava
    Pages 115-131
  8. Pratima Ramful Srivastava
    Pages 133-142
  9. Back Matter
    Pages 143-176

About this book

Introduction

Recreational drug policies and regulations are complex issues with many dimensions. This book attempts to answer several questions raised in current drug policy debates. Developing cost-effective drug programs and policies require a sound knowledge of drug users and their characteristics and the relationship across drugs. Who are the drug users? Can demographic factors help towards predicting drug usage? What sub-population groups should be targeted for drug campaigns and educational programs? Can a drug policy aimed at discouraging the use of one drug likely affect the use of other drugs which are its economic substitutes or complements? What are the implications of drug use? Policymakers and researchers in the area of health and social development would find this book very useful.​

Keywords

Decriminalization Demographics Drug policy Drug use Illicit drugs Recreational drugs

Authors and affiliations

  • Pratima Ramful Srivastava
    • 1
  1. 1.School of Economics, Finance & MarketingRMIT UniversityMelbourneAustralia

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-02405-9
  • Copyright Information Springer International Publishing Switzerland 2013
  • Publisher Name Springer, Cham
  • eBook Packages Business and Economics
  • Print ISBN 978-3-319-02404-2
  • Online ISBN 978-3-319-02405-9
  • Series Print ISSN 0927-4987
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology